Liquid biopsy technology is a non-invasive diagnostic approach that involves the analysis of biomarkers and genetic material (such as circulating tumor DNA or ctDNA) present in body fluids, primarily blood, to detect and monitor various diseases, especially cancer. Unlike traditional biopsies that involve invasive procedures to collect tissue samples, liquid biopsy offers a less invasive and potentially more convenient method for disease detection and monitoring.
麻豆原创 Analysis and Insights: Global Liquid Biopsy Technology 麻豆原创
The global Liquid Biopsy Technology market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global market for liquid biopsy technology has been experiencing substantial growth in recent years, driven by the increasing prevalence of cancer and other chronic diseases, the demand for non-invasive diagnostic methods, and advancements in genomic research and personalized medicine. The demand for liquid biopsy technology varies across different regions, with key markets located in North America, Europe, Asia-Pacific, and other regions with a high burden of cancer and robust research infrastructure. North America, including the United States and Canada, has been a dominant market for liquid biopsy technology due to the presence of well-established healthcare systems, high incidence of cancer, and strong investment in medical research. The global market for liquid biopsy technology is expected to continue growing in the coming years, driven by ongoing advancements in genomic research, increasing adoption of personalized medicine, and the need for non-invasive diagnostic solutions.
Report Covers:
This report presents an overview of global market for Liquid Biopsy Technology market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liquid Biopsy Technology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liquid Biopsy Technology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liquid Biopsy Technology revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Liquid Biopsy Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Liquid Biopsy Technology revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc
Segment by Type
CTCs
ctDNA
Exosomes
Segment by Application
Blood Sample
Urine Sample
Other Bio Fluids
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Liquid Biopsy Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy Technology companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liquid Biopsy Technology revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Liquid Biopsy Technology 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 CTCs
1.2.3 ctDNA
1.2.4 Exosomes
1.3 麻豆原创 by Application
1.3.1 Global Liquid Biopsy Technology 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Blood Sample
1.3.3 Urine Sample
1.3.4 Other Bio Fluids
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Biopsy Technology 麻豆原创 Perspective (2019-2030)
2.2 Global Liquid Biopsy Technology Growth Trends by Region
2.2.1 Liquid Biopsy Technology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liquid Biopsy Technology Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Liquid Biopsy Technology Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Liquid Biopsy Technology 麻豆原创 Dynamics
2.3.1 Liquid Biopsy Technology Industry Trends
2.3.2 Liquid Biopsy Technology 麻豆原创 Drivers
2.3.3 Liquid Biopsy Technology 麻豆原创 Challenges
2.3.4 Liquid Biopsy Technology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Liquid Biopsy Technology by Players
3.1.1 Global Liquid Biopsy Technology Revenue by Players (2019-2024)
3.1.2 Global Liquid Biopsy Technology Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Liquid Biopsy Technology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Liquid Biopsy Technology, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Liquid Biopsy Technology 麻豆原创 Concentration Ratio
3.4.1 Global Liquid Biopsy Technology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy Technology Revenue in 2023
3.5 Global Key Players of Liquid Biopsy Technology Head office and Area Served
3.6 Global Key Players of Liquid Biopsy Technology, Product and Application
3.7 Global Key Players of Liquid Biopsy Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Biopsy Technology Breakdown Data by Type
4.1 Global Liquid Biopsy Technology Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Liquid Biopsy Technology Forecasted 麻豆原创 Size by Type (2025-2030)
5 Liquid Biopsy Technology Breakdown Data by Application
5.1 Global Liquid Biopsy Technology Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Liquid Biopsy Technology Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Liquid Biopsy Technology 麻豆原创 Size (2019-2030)
6.2 North America Liquid Biopsy Technology 麻豆原创 Size by Type
6.2.1 North America Liquid Biopsy Technology 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Liquid Biopsy Technology 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Liquid Biopsy Technology 麻豆原创 Share by Type (2019-2030)
6.3 North America Liquid Biopsy Technology 麻豆原创 Size by Application
6.3.1 North America Liquid Biopsy Technology 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Liquid Biopsy Technology 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Liquid Biopsy Technology 麻豆原创 Share by Application (2019-2030)
6.4 North America Liquid Biopsy Technology 麻豆原创 Size by Country
6.4.1 North America Liquid Biopsy Technology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Liquid Biopsy Technology 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Liquid Biopsy Technology 麻豆原创 Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Liquid Biopsy Technology 麻豆原创 Size (2019-2030)
7.2 Europe Liquid Biopsy Technology 麻豆原创 Size by Type
7.2.1 Europe Liquid Biopsy Technology 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Liquid Biopsy Technology 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Liquid Biopsy Technology 麻豆原创 Share by Type (2019-2030)
7.3 Europe Liquid Biopsy Technology 麻豆原创 Size by Application
7.3.1 Europe Liquid Biopsy Technology 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Liquid Biopsy Technology 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Liquid Biopsy Technology 麻豆原创 Share by Application (2019-2030)
7.4 Europe Liquid Biopsy Technology 麻豆原创 Size by Country
7.4.1 Europe Liquid Biopsy Technology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Liquid Biopsy Technology 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Liquid Biopsy Technology 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Liquid Biopsy Technology 麻豆原创 Size (2019-2030)
8.2 China Liquid Biopsy Technology 麻豆原创 Size by Type
8.2.1 China Liquid Biopsy Technology 麻豆原创 Size by Type (2019-2024)
8.2.2 China Liquid Biopsy Technology 麻豆原创 Size by Type (2025-2030)
8.2.3 China Liquid Biopsy Technology 麻豆原创 Share by Type (2019-2030)
8.3 China Liquid Biopsy Technology 麻豆原创 Size by Application
8.3.1 China Liquid Biopsy Technology 麻豆原创 Size by Application (2019-2024)
8.3.2 China Liquid Biopsy Technology 麻豆原创 Size by Application (2025-2030)
8.3.3 China Liquid Biopsy Technology 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Liquid Biopsy Technology 麻豆原创 Size (2019-2030)
9.2 Asia Liquid Biopsy Technology 麻豆原创 Size by Type
9.2.1 Asia Liquid Biopsy Technology 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Liquid Biopsy Technology 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Liquid Biopsy Technology 麻豆原创 Share by Type (2019-2030)
9.3 Asia Liquid Biopsy Technology 麻豆原创 Size by Application
9.3.1 Asia Liquid Biopsy Technology 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Liquid Biopsy Technology 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Liquid Biopsy Technology 麻豆原创 Share by Application (2019-2030)
9.4 Asia Liquid Biopsy Technology 麻豆原创 Size by Region
9.4.1 Asia Liquid Biopsy Technology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Liquid Biopsy Technology 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Liquid Biopsy Technology 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Liquid Biopsy Technology 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Exact Sciences
11.1.1 Exact Sciences Company Details
11.1.2 Exact Sciences Business Overview
11.1.3 Exact Sciences Liquid Biopsy Technology Introduction
11.1.4 Exact Sciences Revenue in Liquid Biopsy Technology Business (2019-2024)
11.1.5 Exact Sciences Recent Developments
11.2 Guardant Health
11.2.1 Guardant Health Company Details
11.2.2 Guardant Health Business Overview
11.2.3 Guardant Health Liquid Biopsy Technology Introduction
11.2.4 Guardant Health Revenue in Liquid Biopsy Technology Business (2019-2024)
11.2.5 Guardant Health Recent Developments
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Liquid Biopsy Technology Introduction
11.3.4 Natera Revenue in Liquid Biopsy Technology Business (2019-2024)
11.3.5 Natera Recent Developments
11.4 Bio-Techne
11.4.1 Bio-Techne Company Details
11.4.2 Bio-Techne Business Overview
11.4.3 Bio-Techne Liquid Biopsy Technology Introduction
11.4.4 Bio-Techne Revenue in Liquid Biopsy Technology Business (2019-2024)
11.4.5 Bio-Techne Recent Developments
11.5 LabCorp
11.5.1 LabCorp Company Details
11.5.2 LabCorp Business Overview
11.5.3 LabCorp Liquid Biopsy Technology Introduction
11.5.4 LabCorp Revenue in Liquid Biopsy Technology Business (2019-2024)
11.5.5 LabCorp Recent Developments
11.6 Endress+Hauser
11.6.1 Endress+Hauser Company Details
11.6.2 Endress+Hauser Business Overview
11.6.3 Endress+Hauser Liquid Biopsy Technology Introduction
11.6.4 Endress+Hauser Revenue in Liquid Biopsy Technology Business (2019-2024)
11.6.5 Endress+Hauser Recent Developments
11.7 MDxHealth
11.7.1 MDxHealth Company Details
11.7.2 MDxHealth Business Overview
11.7.3 MDxHealth Liquid Biopsy Technology Introduction
11.7.4 MDxHealth Revenue in Liquid Biopsy Technology Business (2019-2024)
11.7.5 MDxHealth Recent Developments
11.8 MutantDx
11.8.1 MutantDx Company Details
11.8.2 MutantDx Business Overview
11.8.3 MutantDx Liquid Biopsy Technology Introduction
11.8.4 MutantDx Revenue in Liquid Biopsy Technology Business (2019-2024)
11.8.5 MutantDx Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Liquid Biopsy Technology Introduction
11.9.4 Thermo Fisher Scientific Revenue in Liquid Biopsy Technology Business (2019-2024)
11.9.5 Thermo Fisher Scientific Recent Developments
11.10 Norgen Biotek
11.10.1 Norgen Biotek Company Details
11.10.2 Norgen Biotek Business Overview
11.10.3 Norgen Biotek Liquid Biopsy Technology Introduction
11.10.4 Norgen Biotek Revenue in Liquid Biopsy Technology Business (2019-2024)
11.10.5 Norgen Biotek Recent Developments
11.11 Nucleix
11.11.1 Nucleix Company Details
11.11.2 Nucleix Business Overview
11.11.3 Nucleix Liquid Biopsy Technology Introduction
11.11.4 Nucleix Revenue in Liquid Biopsy Technology Business (2019-2024)
11.11.5 Nucleix Recent Developments
11.12 OraSure Technologies
11.12.1 OraSure Technologies Company Details
11.12.2 OraSure Technologies Business Overview
11.12.3 OraSure Technologies Liquid Biopsy Technology Introduction
11.12.4 OraSure Technologies Revenue in Liquid Biopsy Technology Business (2019-2024)
11.12.5 OraSure Technologies Recent Developments
11.13 Qiagen
11.13.1 Qiagen Company Details
11.13.2 Qiagen Business Overview
11.13.3 Qiagen Liquid Biopsy Technology Introduction
11.13.4 Qiagen Revenue in Liquid Biopsy Technology Business (2019-2024)
11.13.5 Qiagen Recent Developments
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Liquid Biopsy Technology Introduction
11.14.4 Bio-Rad Laboratories Revenue in Liquid Biopsy Technology Business (2019-2024)
11.14.5 Bio-Rad Laboratories Recent Developments
11.15 Biocartis
11.15.1 Biocartis Company Details
11.15.2 Biocartis Business Overview
11.15.3 Biocartis Liquid Biopsy Technology Introduction
11.15.4 Biocartis Revenue in Liquid Biopsy Technology Business (2019-2024)
11.15.5 Biocartis Recent Developments
11.16 NeoGenomics
11.16.1 NeoGenomics Company Details
11.16.2 NeoGenomics Business Overview
11.16.3 NeoGenomics Liquid Biopsy Technology Introduction
11.16.4 NeoGenomics Revenue in Liquid Biopsy Technology Business (2019-2024)
11.16.5 NeoGenomics Recent Developments
11.17 Sysmex Inostics
11.17.1 Sysmex Inostics Company Details
11.17.2 Sysmex Inostics Business Overview
11.17.3 Sysmex Inostics Liquid Biopsy Technology Introduction
11.17.4 Sysmex Inostics Revenue in Liquid Biopsy Technology Business (2019-2024)
11.17.5 Sysmex Inostics Recent Developments
11.18 Menarini Silicon Biosystems
11.18.1 Menarini Silicon Biosystems Company Details
11.18.2 Menarini Silicon Biosystems Business Overview
11.18.3 Menarini Silicon Biosystems Liquid Biopsy Technology Introduction
11.18.4 Menarini Silicon Biosystems Revenue in Liquid Biopsy Technology Business (2019-2024)
11.18.5 Menarini Silicon Biosystems Recent Developments
11.19 Biocept
11.19.1 Biocept Company Details
11.19.2 Biocept Business Overview
11.19.3 Biocept Liquid Biopsy Technology Introduction
11.19.4 Biocept Revenue in Liquid Biopsy Technology Business (2019-2024)
11.19.5 Biocept Recent Developments
11.20 ANGLE plc
11.20.1 ANGLE plc Company Details
11.20.2 ANGLE plc Business Overview
11.20.3 ANGLE plc Liquid Biopsy Technology Introduction
11.20.4 ANGLE plc Revenue in Liquid Biopsy Technology Business (2019-2024)
11.20.5 ANGLE plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc
听
听
*If Applicable.
